INTRODUCTION
Tuberculosis is still a high mortality disease and major public health issue even in developed countries. In Japan, 13.9 cases per 1 million persons were annually diagnosed with tuberculosis in 2016, and Japan is considered as a middle-burden country. [9, 23] ere were 77.2% of cases with pulmonary disease with or without concomitant extrapulmonary disease, and 22.8% of these cases had extrapulmonary disease. [24] is epidemiology coincides with that in Japan, in which extra-pulmonary disease accounts for 14.8-31.8% in all age cases.
A paradoxical reaction (PR) is a phenomenon in which the primary tuberculous lesion worsens or another de novo tuberculous lesion appears during anti-tuberculous therapy although clinical symptoms improve initially after antituberculous therapy. [1, 5, 7, 11] The mechanism of a PR is neither a therapeutic failure nor drug resistance to Mycobacterium tuberculosis but rather an exaggerated immune reaction. The incidence of cases with a PR is higher in patients with an extrapulmonary lesion (82% of all cases) compared to that of patients with a pulmonary lesion. [2] For intracranial tuberculosis, 56% of tuberculous meningitis patients had a PR, and 20-56% of these patients had a complicated de novo tuberculoma. [6, 22] Tuberculoma may occur followed by tuberculous meningitis, and the incidence of tuberculoma alone with a PR is rare. [2, 20] Hereby, we experienced a rare surgical case of cerebellar tuberculoma caused by a PR during antituberculous therapy for tuberculous spondylitis. We report clinical characteristics of this patient and describe this case compared to previous studies.
CASE REPORT
A 47-year-old male with seronegative human immunodeficiency virus (HIV) and diabetes mellitus suffered from lower back pain. He was diagnosed with bacterial spondylitis and iliopsoas abscess [ Figure 1a ]. Multiple antibacterial agents were prescribed, but the lesion did not disappear. M. tuberculosis was detected from the abscess, and caseous granuloma was identified pathologically in surgical specimens of the intervertebral disk [ Figure 1b ]. He was prescribed the antituberculous agents which were isoniazid 300 mg, rifampicin 600 mg, ethambutol 1000 mg, and pyrazinamide 1500 mg/day. His lower back pain and inflammatory findings improved by the antituberculous therapy.
Two months after starting the antituberculous therapy, he complained of headache, nausea, and staggering. Physical findings on admission were that he was afebrile and did not have stiff neck. A right coordination deficit was identified, and other neurological deficits did not exist. Laboratory findings did not show inflammatory reaction. Chest computed tomography (CT) did not show any cavity lesions. Magnetic resonance (MR) images revealed a nodular enhanced lesion in the right cerebellar hemisphere extending to the vermis associated perifocal edema and bilateral ventriculomegaly [ Figure 2 ]. e lesion showed hypointensity by diffusionattenuated, weighted images.
Tuberculoma was suspected which appeared de novo or enlarged during the antituberculous therapy that was suggested to be a PR. e therapeutic strategy was a lesionectomy because he presented noncommunicating hydrocephalus, and malignant glioma could not be ruled out completely. Lesionectomy would be thought to relief noncommunicating hydrocephalus, and we did not plan to perform ventricular shunt.
Surgery was performed by a midline occipital approach. A well-circumscribed mass with gray color was identified by opening the cerebellomedullary fissure [ Figure 3 Figure 4b ]. He recovered well from nausea and staggering and was discharged 3 weeks after the operation. He was prescribed antituberculous agents which were isoniazid, rifampicin, ethambutol, and pyrazinamide for the first 2 months and then isoniazid and rifampicin for up to 10 months according to the guideline for the treatment of tuberculosis of central nervous system. [23] DISCUSSION e pathological mechanism of a PR is an exaggerated immunological reaction to viable microbes and debris of microbes destroyed by antituberculous therapy. is mechanism has been studied among patients who are coinfected with HIV and M. tuberculosis and received antiretroviral therapy (ART) and is relevant to the pathology of immune reconstitution inflammatory disease. [5, 12, 15] Although a PR is less frequent in HIV-seronegative patients compared to HIV-positive patients receiving ART, [16] immune-competent patients may have a PR induced by antituberculous therapy through an exaggerated immune reaction to a latent tuberculous lesion involving production of pro-inflammatory cytokines. [21] Intracranial tuberculoma occurs in 1% of tuberculous patients. [10] e causative mechanism of the development of intracranial tuberculoma is hematogenous infection from distant tuberculous lesions or a PR of preceding tuberculous meningitis. [8] e incidence of tuberculoma without preceding meningitis is 5% among intracranial tuberculosis, and few papers report PR of tuberculoma alone. [2, 6] e standard management of intracranial tuberculosis is the initiation of antituberculous therapy for 12 months based on a regimen for pulmonary tuberculosis. In particular, isoniazid and pyradinamide may pass the blood-brain barrier. e optimal duration for antituberculous therapy for patients with PR of tuberculosis of central nervous system is not reported. We referred to the guideline published by British Infection Society and decide to continue antituberculous therapy for 12 months, permitting another additional 6 months according to their response. [3, 23] Concurrent use of corticosteroids is beneficial for pediatric and adult patients who are HIV seronegative and recommended because it suppresses exaggerated immune reactions and improves perilesional brain edema which leads to diminish neurological symptoms. [14, 18, 23] Surgery is also considered for cases with both primary intracranial tuberculosis and an intracranial tuberculous lesion caused by a PR in case of serial complications of hydrocephalus and a mass effect. [17] Shunt implantation and endoscopic third ventriculostomy are a therapeutic option for hydrocephalus. [19] Lesionectomy is also another therapeutic option for patients not effectively treated by antituberculous therapy, but only a few surgical cases have been reported. [4, 16] Here, we treated an immune-competent case with cerebellar tuberculoma caused by a PR during the therapy for tuberculous spondylitis. e cerebellar tuberculoma was suggested to be formed by PR against the preceding nonsymptomatic M. tuberculosis lesion in the cerebellum hematogenously infected from tuberculous spondylitis. He did not have a preceding clinical history of meningitis. Although the symptoms and clinical findings of tuberculous spondylitis markedly recovered after antituberculous therapy, annual neurological symptoms occurred after 2 months. e initiation of antituberculous therapy may induce the enlargement of the cerebellar lesion, which is considered a PR. Recently, it is reported that vertebral involvement of M. tuberculosis infection is a risk factor for PR of tuberculosis in central nervous system, which would support the clinical features of this case. [13] Furthermore, a pathological finding from the surgical specimen, which showed an aggregation of inflammatory cells with caseous granuloma and lack of M. tuberculosis, suggested that the mass was formed by an inflammatory process and neither by active tuberculous activity, drug resistance nor difficulties about drug delivery of antituberculous agents. [18] In our case, it was obvious that the cerebellar lesion caused the obstruction of the fourth ventricle, and he presented with symptoms of hydrocephalus. Lesionectomy was effective to improve his neurological symptoms caused by noncommunicating hydrocephalus and contributed to the precise pathological diagnosis.
Limitations of the present case were that the patient had not taken brain CT scans or MR images ahead of antituberculous therapy, and we could not identify when the lesion formed. However, he did not show any neurological symptoms before antituberculous therapy and enlargement of the lesion produced neurological disorders after the initiation of antituberculous therapy.
CONCLUSION
We treated a patient who had cerebellar tuberculoma caused by a PR and presented with neurological disorders during therapy for tuberculous spondylitis. Antituberculous therapy is the first choice for tuberculoma manifesting PR. Concurrent use of corticosteroids is recommended because of suppressing exaggerated immune reaction in tuberculoma causing PR and reducing perilesional brain edema. Surgery is considered for localized tuberculoma causing neurological symptoms.
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